Antiabortion Activists Hone In On Medication Abortion Restrictions As Pro-Choice Sens. Urge FDA To Finalize REMS

By Bridget Early / November 29, 2022 at 1:32 PM
Republicans and antiabortion activists have set their sights on restricting access to medication abortions as part of their agenda for the year ahead, a strategy reproductive rights advocates worried would crop up in the wake of Dobbs v. Jackson Women’s Health Organization . FDA faces a new lawsuit over its expedited approval process for mifepristone, as well as a petition urging the agency to require providers to handle fetal remains as medical waste. Both efforts could make it more challenging...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.